...
首页> 外文期刊>Chest: The Journal of Circulation, Respiration and Related Systems >Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size.
【24h】

Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size.

机译:非大小型AJCC T2描述子的预后意义:IB期非小细胞肺癌的内脏胸膜浸润,肺门肺不张或阻塞性肺炎取决于肿瘤大小。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The T2 descriptor for staging non-small cell lung cancer (NSCLC) contains several non-size-based criteria. It remains unknown whether the prognostic significance of these non-size-based criteria is dependent on tumor size. METHODS: A total of 10,545 patients with stage IB NSCLC from the California Cancer Registry between 1989 to 2003 were categorized into the following three nonoverlapping criteria: (1) tumor size (T2S); (2) visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis (T2P); and (3) main bronchus involvement > or = 2 cm from the carina (T2C). Univariate survival analyses were performed using the Kaplan-Meier method. Multivariate survival analyses were performed using Cox proportional hazards ratios. RESULTS: A total of 51.1% of patients with stage IB NSCLC were staged by T2S, 43.2% by T2P, and 5.7% by T2C; 2,224 stage IB patients (total, 21.1%; 18.9% T2P + 2.2% T2C) had tumors < or = 3 cm in size. The 5-year survival rate and the median survival time of these stage IB patients with tumors < or = 3 cm in size were as follows: T2P, 51.2% and 64 months, respectively; T2C, 49.0% and 58 months, respectively. These values were similar to the 53.2% 5-year survival rate and 67-month median survival time for patients with stage IA NSCLC (p = 0.40). Cox proportional hazards model revealed T2P of > 3 cm was a poor prognostic factor for survival (vs T2S; hazard ratio [HR], 1.16; 95% confidence interval [CI], 1.08 to 1.24). Conversely, T2P < or = 3 cm was a favorable prognostic factor for survival (vs T2S; HR, 0.89; 95% CI, 0.82 to 0.96). T2C was not an independent prognostic factor for survival. CONCLUSIONS: Prognostic significance of the non-size-based T2 descriptor T2P is dependent on tumor size.
机译:背景:用于分期非小细胞肺癌(NSCLC)的T2描述符包含多个非基于大小的标准。这些基于非大小的标准的预后意义是否取决于肿瘤大小,目前尚不清楚。方法:将1989年至2003年间来自加利福尼亚癌症登记处的10,545例IB期NSCLC患者分为以下三个不重叠的标准:(1)肿瘤大小(T2S); (2)内脏胸膜浸润,肺门肺不张或阻塞性肺炎(T2P); (3)主支气管受累距离距隆突(T2C)≥2 cm。使用Kaplan-Meier方法进行单因素生存分析。使用Cox比例风险比进行多因素生存分析。结果:IB分期的非小细胞肺癌患者中,有51.1%通过T2S分期,有43.2%通过T2P分期,有5.7%通过T2C分期。 2224名IB期患者(总数,占21.1%; 18.9%的T2P + 2.2%的T2C)肿瘤大小≤3 cm。这些肿瘤小于或等于3 cm的IB期患者的5年生存率和中位生存时间分别为:T2P,51.2%和64个月。 T2C分别为49.0%和58个月。这些值类似于IA期NSCLC患者的53.2%的5年生存率和67个月的中位生存时间(p = 0.40)。 Cox比例风险模型显示,T2P> 3 cm是生存率低的预后因素(vs T2S;风险比[HR]为1.16; 95%置信区间[CI]为1.08至1.24)。相反,T2P <或= 3 cm是生存的有利预后因素(vs T2S; HR,0.89; 95%CI,0.82至0.96)。 T2C不是生存的独立预后因素。结论:非基于大小的T2描述符T2P的预后意义取决于肿瘤大小。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号